BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 26447779)

  • 1. Potential Mechanisms for Cancer Resistance in Elephants and Comparative Cellular Response to DNA Damage in Humans.
    Abegglen LM; Caulin AF; Chan A; Lee K; Robinson R; Campbell MS; Kiso WK; Schmitt DL; Waddell PJ; Bhaskara S; Jensen ST; Maley CC; Schiffman JD
    JAMA; 2015 Nov; 314(17):1850-60. PubMed ID: 26447779
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Sulak M; Fong L; Mika K; Chigurupati S; Yon L; Mongan NP; Emes RD; Lynch VJ
    Elife; 2016 Sep; 5():. PubMed ID: 27642012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Illuminating Cancer Resistance in Elephants.
    Cancer Discov; 2015 Dec; 5(12):1229. PubMed ID: 26493958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TP53 Gene and Cancer Resistance in Elephants.
    Pessier AP; Stern JK; Witte CL
    JAMA; 2016 Apr; 315(16):1789. PubMed ID: 27115385
    [No Abstract]   [Full Text] [Related]  

  • 5. TP53 Gene and Cancer Resistance in Elephants.
    Perez RP; Komiya T
    JAMA; 2016 Apr; 315(16):1789-90. PubMed ID: 27115384
    [No Abstract]   [Full Text] [Related]  

  • 6. TP53 Gene and Cancer Resistance in Elephants.
    Casola C
    JAMA; 2016 Apr; 315(16):1788-9. PubMed ID: 27115383
    [No Abstract]   [Full Text] [Related]  

  • 7. TP53 Gene and Cancer Resistance in Elephants--Reply.
    Schiffman JD; Schmitt DL; Maley CC
    JAMA; 2016 Apr; 315(16):1790-1. PubMed ID: 27115386
    [No Abstract]   [Full Text] [Related]  

  • 8. Evolutionary Adaptations to Risk of Cancer: Evidence From Cancer Resistance in Elephants.
    Greaves M; Ermini L
    JAMA; 2015 Nov; 314(17):1806-7. PubMed ID: 26447685
    [No Abstract]   [Full Text] [Related]  

  • 9. A Zombie LIF Gene in Elephants Is Upregulated by TP53 to Induce Apoptosis in Response to DNA Damage.
    Vazquez JM; Sulak M; Chigurupati S; Lynch VJ
    Cell Rep; 2018 Aug; 24(7):1765-1776. PubMed ID: 30110634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome.
    Tabori U; Nanda S; Druker H; Lees J; Malkin D
    Cancer Res; 2007 Feb; 67(4):1415-8. PubMed ID: 17308077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elephant Genomes Reveal Accelerated Evolution in Mechanisms Underlying Disease Defenses.
    Tollis M; Ferris E; Campbell MS; Harris VK; Rupp SM; Harrison TM; Kiso WK; Schmitt DL; Garner MM; Aktipis CA; Maley CC; Boddy AM; Yandell M; Gregg C; Schiffman JD; Abegglen LM
    Mol Biol Evol; 2021 Aug; 38(9):3606-3620. PubMed ID: 33944920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new genotoxicity assay based on p53 target gene induction.
    Zerdoumi Y; Kasper E; Soubigou F; Adriouch S; Bougeard G; Frebourg T; Flaman JM
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Aug; 789-790():28-35. PubMed ID: 26232255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of germline or somatic TP53 missense mutation with oncogene amplification in tumors developed in patients with Li-Fraumeni or Li-Fraumeni-like syndrome.
    Sugawara W; Arai Y; Kasai F; Fujiwara Y; Haruta M; Hosaka R; Nishida K; Kurosumi M; Kobayashi Y; Akagi K; Kaneko Y
    Genes Chromosomes Cancer; 2011 Jul; 50(7):535-45. PubMed ID: 21484931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drastic effect of germline TP53 missense mutations in Li-Fraumeni patients.
    Zerdoumi Y; Aury-Landas J; Bonaïti-Pellié C; Derambure C; Sesboüé R; Renaux-Petel M; Frebourg T; Bougeard G; Flaman JM
    Hum Mutat; 2013 Mar; 34(3):453-61. PubMed ID: 23172776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How elephants beat cancer.
    Gaughran SJ; Pless E; Stearns SC
    Elife; 2016 Oct; 5():. PubMed ID: 27797705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
    Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
    Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 and hereditary cancer.
    Merino D; Malkin D
    Subcell Biochem; 2014; 85():1-16. PubMed ID: 25201186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of sequence tagged sites in the Asian and African elephant.
    Burk NE; Messer LA; Ernst CW; Rothschild MF
    Anim Biotechnol; 1998; 9(2):155-60. PubMed ID: 9713680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic modeling of Li-Fraumeni syndrome in zebrafish.
    Parant JM; George SA; Holden JA; Yost HJ
    Dis Model Mech; 2010; 3(1-2):45-56. PubMed ID: 20075382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant p21WAF1-dependent growth arrest as the possible mechanism of abnormal resistance to ultraviolet light cytotoxicity in Li-Fraumeni syndrome fibroblast strains heterozygous for TP53 mutations.
    Barley RD; Enns L; Paterson MC; Mirzayans R
    Oncogene; 1998 Aug; 17(5):533-43. PubMed ID: 9704919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.